Retatrutides prescription availability in Canada is projected to follow Phase 3 trial completion and regulatory review, likely beginning in 2026 at the earliest
Clear pricing, real providers, and support that actually replies
Our medical team will design a tailored protocol to support fat metabolism, body composition, and long-term metabolic health through safe, science-backed care.
Faded hyperpigmentation: Documented in Finkley 2005 as reduced mottled pigmentation, supported by GHK-Cus MMP-modulating activity
B12 injections have shown promising results in improving energy levels, appetite, and overall immune function in FIP cats, thereby enhancing their quality of life
HPLC-UV validation is standard